Advertisement

Role of Neuropeptide Y and Dipeptidyl Peptidase IV in Regulation of Ewing’s Sarcoma Growth

  • Joanna Kitlinska
  • Lydia Kuo
  • Ken Abe
  • Jennifer Pons
  • Muchieh Yu
  • Lijun Li
  • Jason Tilan
  • Jeffrey Toretsky
  • Zofia Zukowska
Part of the Advances in Experimental Medicine and Biology book series (volume 575)

Keywords

TC32 Cell Dipeptidyl Peptidase Peripheral Primitive Neuroectodermal Tumor DPPIV Inhibitor Sarcoma Growth 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beltinger C and Debatin KM, 2001, Murine models for experimental therapy of pediatric solid tumors with poor prognosis. Int J Cancer. 92: 313–318.CrossRefPubMedGoogle Scholar
  2. Biedler JL, Helson L and Spengler BA, 1973, Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33: 2643–2652.PubMedGoogle Scholar
  3. Burchill SA, 2003, Ewing’s sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities. J Clin Pathol. 56: 96–102.CrossRefPubMedGoogle Scholar
  4. Chansky HA, Hu M, Hickstein DD and Yang L, 2001, Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Res. 61: 3586–3590.PubMedGoogle Scholar
  5. Colmers WF and Wahlestedt C, 1993, The Biology of Neuropeptide and Related Peptides, p. xvi, 564. Totowa, NJ, Humana Press.Google Scholar
  6. de Alava E and Gerald WL, 2000, Molecular biology of the Ewing’s sarcoma/primitive neuroectodermal tumor family. J Clin Oncol. 18: 204–213.PubMedGoogle Scholar
  7. Ekstrand AJ, Cao R, Bjorndahl M, Nystrom S, Jonsson-Rylander AC, Hassani H, Hallberg B, NordlanderMand Cao Y, 2003, Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc Natl Acad Sci USA. 100: 6033–6038.CrossRefPubMedGoogle Scholar
  8. Fabry M, Langer M, Rothen-Rutishauser B, Wunderli-Allenspach H, Hocker H and Beck-Sickinger AG, 2000, Monitoring of the internalization of neuropeptide Y on neuroblastoma cell line SK-N-MC. Eur J Biochem. 267: 5631–5637.CrossRefPubMedGoogle Scholar
  9. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA and Weinshank RL, 1996, A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382: 168–171.CrossRefPubMedGoogle Scholar
  10. Ghersi G, Chen W, Lee EW and Zukowska Z, 2001, Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides. 22: 453–458.CrossRefPubMedGoogle Scholar
  11. Langer M, Kratz F, Rothen-Rutishauser B, Wunderli-Allenspach H and Beck-Sickinger AG, 2001, Novel peptide conjugates for tumor-specific chemotherapy. J Med Chem. 44: 1341–1348.CrossRefPubMedGoogle Scholar
  12. Grundemar L and B SR, 1997, Neuropeptide Y and Drug Development. San Diego, London, Academic Press.Google Scholar
  13. Hansel DE, Eipper BA and Ronnett GV, 2001, Neuropeptide Y functions as a neuroproliferative factor. Nature. 410: 940–944.CrossRefPubMedGoogle Scholar
  14. Kitlinska J, Abe K, Kuo L, Pons J, Yu M, Li L, Tilan J, Everhart L, Lee EW, Zukowska Z and Toretsky JA, 2005, Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Res. 65: 1719–1728.CrossRefPubMedGoogle Scholar
  15. Koulu M, Movafagh S, Tuohimaa J, Jaakkola U, Kallio J, Pesonen U, Geng Y, Karvonen MK, Vainio-Jylha E, Pollonen M, Kaipio-Salmi K, Seppala H, Lee EW, Higgins RD and Zukowska Z, 2004, Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization. Ann Med. 36: 232–240.CrossRefPubMedGoogle Scholar
  16. Kovar H, 2003, Ewing tumor biology: perspectives for innovative treatment approaches. Adv Exp Med Biol. 532: 27–37.PubMedGoogle Scholar
  17. Larhammar D, Blomqvist AG, Yee F, Jazin E, Yoo H and Wahlestedt C, 1992, Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem. 267: 10935–10938.PubMedGoogle Scholar
  18. Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P, Sangkharat A, Ji H, Li L, Michalkiewicz T, Ljubisavljevic M, Johansson H, Grant DS and Zukowska Z, 2003, Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest. 111: 1853–1862.CrossRefPubMedGoogle Scholar
  19. Lee EW, Grant DS, Movafagh S and Zukowska Z, 2003, Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice. Peptides. 24: 99–106.CrossRefPubMedGoogle Scholar
  20. Lessnick SL, Braun BS, Denny CT, and May WA, 1995, Multiple domains mediate transformation by the Ewing’s sarcoma EWS/FLI-1 fusion gene. Oncogene. 10: 423–431.PubMedGoogle Scholar
  21. Mentlein R, 1999, Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept. 85: 9–24.CrossRefPubMedGoogle Scholar
  22. Pons J, Kitlinska J, Ji H, Lee EW and Zukowska Z, 2003, Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system. Can J Physiol Pharmacol. 81: 177–185.CrossRefPubMedGoogle Scholar
  23. Reubi JC, Gugger M, Waser B and Schaer JC, 2001, Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets. Cancer Res. 61: 4636–4641.PubMedGoogle Scholar
  24. Rodriguez-Galindo C, Spunt SL, and Pappo AS, 2003, Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. Med Pediatr Oncol. 40: 276–287.CrossRefPubMedGoogle Scholar
  25. Rose PM, Fernandes P, Lynch JS, Frazier ST, Fisher SM, Kodukula K, Kienzle B and Seethala R, 1995, Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem. 270: 29038.PubMedGoogle Scholar
  26. Shorter NA and Pence JC, 1997, Retinoic acid-induced regulation of neuropeptide Y receptor expression and function in the neuroepithelioma line SK-N-MC. J Pediatr Surg. 32: 721–723.CrossRefPubMedGoogle Scholar
  27. van Valen F, Winkelmann W and Jurgens H, 1992, Expression of functional Y1 receptors for neuropeptide Y in human Ewing’s sarcoma cell lines. J Cancer Res Clin Oncol. 118: 529–536.CrossRefPubMedGoogle Scholar
  28. Whang-Peng J, Triche TJ, Knutsen T, Miser J, Kao-Shan S, Tsai S and Israel MA, 1986, Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet. 21: 185–208.CrossRefPubMedGoogle Scholar
  29. Zukowska-Grojec Z and Wahlestedt C, 1993, Origin and actions of neuropeptide Y in the cardiovascular system. In: Colmers WF and Wahlestedt C (eds.), The biology of neuropeptide Y and related peptides, pp. 315–388. Totowa, NJ, Humana Press.CrossRefGoogle Scholar
  30. Zukowska-Grojec Z, Pruszczyk P, Colton C, Yao J, Shen GH, Myers AK and Wahlestedt C, 1993, Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides. 14: 263–268.CrossRefPubMedGoogle Scholar
  31. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Fisher TA and Ji H, 1998, Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors. Regul Pept. 75–76: 231–238.CrossRefPubMedGoogle Scholar
  32. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y, Chen WT, Kleinman HK, Grouzmann E and Grant DS, 1998a, Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res. 83: 187–195.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Joanna Kitlinska
    • 1
  • Lydia Kuo
    • 1
  • Ken Abe
    • 1
  • Jennifer Pons
    • 1
  • Muchieh Yu
    • 1
  • Lijun Li
    • 1
  • Jason Tilan
    • 1
  • Jeffrey Toretsky
    • 2
  • Zofia Zukowska
    • 1
  1. 1.Department of Physiology and BiophysicsGeorgetown University Medical CenterWashington, DC
  2. 2.Department of Oncology, Lombardi Cancer CenterGeorgetown University Medical CenterWashington, DC

Personalised recommendations